Evidence map›Paper›PMID 41005710›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2025

Comparison of QuPath and HALO Platforms for Analysis of the Tumor Microenvironment in Prostate Cancer.

Wei Zhang, Qin Zhou, Jonathan V Nguyen, Erika Egal, Qian Yang, Michael R Freeman, Siwen Hu-Lieskovan, Gita Suneja, Anna Coghill, Beatrice S Knudsen

Abstract readComparative Study
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Wei ZhangBiorepository and Molecular Pathology Core, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; Department of Pathology, University of Utah, Salt Lake City, Utah. Electronic address: Wei.zhang@hci.utah.edu.
Qin ZhouBiorepository and Molecular Pathology Core, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; Department of Medicine, School of Medicine, University of Utah, Salt Lake City, Utah.
Jonathan V NguyenCenter for Immunization and Infection Research in Cancer, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Erika EgalBiorepository and Molecular Pathology Core, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
Qian YangDepartment of Urology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California; Department of Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Michael R FreemanDepartment of Urology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California; Department of Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Siwen Hu-LieskovanBiorepository and Molecular Pathology Core, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; Department of Medicine, School of Medicine, University of Utah, Salt Lake City, Utah.
Gita SunejaDepartment of Radiation Oncology, University of Utah, Salt Lake City, Utah.
Anna CoghillCenter for Immunization and Infection Research in Cancer, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Beatrice S KnudsenBiorepository and Molecular Pathology Core, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; Department of Pathology, University of Utah, Salt Lake City, Utah. Electronic address: Beatrice.Knudsen@path.utah.edu.

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
AIDS and Cancer Specimen Resource (ACSR)UM1CA181255 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jeffrey Michael Bethony, Anna Coghill · 2013 to 2026
$56.7M
NCI NIH HHS P30 CA042014NCI NIH HHS UM1 CA181255
6 · The paper itself

Abstract

QuPath, an open-source digital pathology platform, has gained widespread use for image analysis in biomedical research since its release in 2016. However, its reproducibility and reliability compared with commercial software, such as HALO, require further validation, particularly for multiplex immunofluorescence analysis. In this study, we performed a direct comparison of QuPath and HALO using a multiplex immunofluorescence-stained prostate cancer tissue microarray inclusive of 192 unique cores. We evaluated performance across 3 key analytical modules: immune cell phenotyping, tumor infiltration with immune cells, and nearest neighbor analysis. Furthermore, we integrated QuPath with CytoMap, an open-source spatial analysis tool, to perform unsupervised clustering of immune cell infiltration-a feature not available in HALO. Our results demonstrated high concordance between 2 platforms, with correlation coefficients >0.89 for immune cell density, distance, and pattern of cell organization in tumor microenvironment. A neighborhood analysis using CytoMap was further performed and provided a more detailed spatial analysis of immune cell distribution across different prostate cancer grades. A significant increase of CD103+ T-cell infiltration into tumor microenvironment was observed in prostate cancer. In conclusion, our findings validate QuPath as a robust and reproducible alternative to commercial platforms for fluorescence-based digital pathology. By demonstrating QuPath's capability to perform high-quality quantitative analysis with additional flexibility for integration with external tools, our study underscores its potential for advancing tumor microenvironment research in translational oncology.

Indexed as

Image Processing, Computer-AssistedProstatic NeoplasmsTumor MicroenvironmentFluorescent Antibody TechniqueHumansMaleReproducibility of ResultsSoftwareTissue Array AnalysisHALOprostate cancerQuPath

Identifiers

PMID41005710
PMCPMC12756938

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.